| 000 | 01173nam a22002897a 4500 | ||
|---|---|---|---|
| 001 | 05897 | ||
| 003 | HDC | ||
| 007 | cr bn ---aaaaa | ||
| 008 | 210122b20052005xxu||||| |||| 00| 0 eng d | ||
| 020 | _a1574448692 | ||
| 040 | _aHDC | ||
| 100 |
_aYourick, Jeffrey J. _eauthor _96211 |
||
| 245 | 0 |
_aPercutaneous Penetration as It Relates to the Safety Evaluation of Cosmetic Ingredients _c/ Jeffrey J. Yourick and Robert L. Bronaugh |
|
| 260 |
_aUnited States: _bTaylor & Francis, _c2005 |
||
| 300 | _a1 online resource (10 pages) | ||
| 336 |
_atext _2rdacontent |
||
| 337 |
_acomputer _2rdamedia |
||
| 338 |
_aonline resource _2rdacarrier |
||
| 500 |
_aOriginally from: Percutaneous absorption : drugs, cosmetics, mechanisms, methodology, 2005 (pages 595-604) _aIncludes bibliographical references |
||
| 650 |
_aSkin absorption _96213 |
||
| 650 |
_aTransdermal medication _96212 |
||
| 700 |
_aBronaugh, Robert L. _ejoint author _96214 |
||
| 856 | _zRequest full-text at [email protected] | ||
| 942 | _2lcc | ||
| 942 | _cCHAP | ||
| 942 | _kEBCH 004205 | ||
| 999 |
_c3221 _d3221 |
||